.............................................................April 1st, 2013
Patrick Muraca, President & CEO Of Nuclea Biotechnologies, Inc., Appointed To Jimmy Fund Visiting Committee
.............................................................Patrick Muraca, President & CEO Of Nuclea Biotechnologies, Inc., Appointed To Jimmy Fund Visiting Committee
Press Releases
Releases - 2013
-
2013
- April 1st, 2013 - Patrick Muraca, President & CEO Of Nuclea Biotechnologies, Inc., Appointed To Jimmy Fund Visiting Committee
- March 20th, 2013 - Nuclea Biotechnologies, Inc. and Wilex Inc. Announce Partnership
Releases - 2012
-
2012
- December 18th, 2012 - Nuclea Biotechnologies Inc. Funds Paul M. Dowd Chair In Molecular Oncologic Pathology At Dana-Farber Cancer Institute
- September 10th, 2012 - Nuclea Biotechnologies To Present Poster On Fatty Acid Synthase At HUPO Annual Meeting
- August 2nd, 2012 - Nuclea Biotechnologies Raises $5 Million In Series C Funding Round
- July 20th, 2012 - Third Annual Nuclea Summer Science Institute Begins Monday
- July 19th, 2012 - Nuclea Biotechnologies Acquires Tissue Microarray Patents
- June 13th, 2012 - Nuclea Biotechnologies is the proud sponsor of the 29th annual Berkshire County Jimmy Fund Golf Classic to support research at Dana Farber Cancer Institute
- April 26th, 2012 - Nuclea Biotechnologies agrees to research partnership with Stratton VA Medical Center in Albany
- April 24th, 2012 - Nuclea Biotechnologies Completes Major Debt Conversion
- March 23rd, 2012 - Nuclea Biotechnologies is Attending The American Association of Cancer Research Annual Meeting
- March 6th, 2012 - Nuclea Biotechnologies Receives U.S. Patent 8,129,125 B2 for EGFR Inhibitor Assay
- February 2nd, 2012 - Nuclea Biotechnologies Announces $3.4 Million in Capital Commitments
- January 11th, 2012 - Nuclea Biotechnologies Submits Pre-Market Filings on Fatty Acid Synthase Assays for FDA Regulatory Review
- January 3rd, 2012 - Nuclea Biotechnologies Receives U.S. Patent 8,088,589 B2 for EGFR Inhibitor Assay
Releases - 2011
-
2011
- September 24th, 2011 - Nuclea Diagnostic Laboratories receives accreditation from College of American Pathologists
- June 3rd, 2011 - Nuclea President Patrick Muraca receives President's Award from Berkshire Community College
- May 12th, 2011 - Nuclea discovery could significantly improve prostate cancer diagnosis, treatment
- April 4th, 2011 - Nuclea Biotechnologies Forms High Performance Computing Clusters With Three Massachusetts Colleges
- March 1st, 2011 - Nuclea Biotechnologies Receives U.S. PATENT 7,897,354 for Kinase Peptides and Antibodies
- February 24th, 2011 - WAMC - Northeast Public Radio - Charlie Deitz
- January 24th, 2011 - Nuclea Biotechnologies Inc. and Boston Medical Center announce unique partnership
- January 10th, 2011 - Nuclea granted notice of allowance on eighth patent
Releases - 2010
-
2010
Nuclea Biotechnologies receives $733,000 federal grant under new health care law; will expand pittsfield workforce by 25% - August 4th, 2010 - Nuclea Biotechnologies, Massachusetts Life Sciences Center and Massbio announce the opening of the Nuclea Genomics Center in Pittsfield
- April 16th, 2010 - Nuclea Biotechnologies, LLC announces today the closing of a $2.5 million dollar private placement
- March 19th, 2010 - wamc northeast public radio - biotech firm partners with berkshire community college
- March 18th, 2010 - Nuclea Biotechnologies in partnering with Berkshire Community College establishes the Nuclea Summer Science Institute for high school and college students
Releases - 2009
-
2009
December 8th, 2009 - Nuclea Diagnostic Laboratories, LLC, a division of Nuclea Biotechnologies, LLC, receives accrediation from the College of American Pathologists - November 5th, 2009 - Nuclea Biotechnologies, LLC announces today the closing of a $3.4 million dollar private placement
- July 8th, 2009 - Nuclea Biotechnologies, LLC announces today the closing of a $1 million dollar private placement
- July 8th, 2009 - Nuclea Biotechnologies, LLC announces today that it has received laboratory certification from the state of Massachusetts
Releases - 2008
-
2008
November 18th, 2008 - Nuclea Relocates to Worcester Massachusetts - November 12th, 2008 - Nuclea Biotechnologies, LLC will offer a new laboratory assay designed to detect the gene/protein expression profile for predicting recurrent colon cancer
- October 10th, 2008 - Nuclea Biotechnologies, LLC will offer a new laboratory assay designed to detect the gene/protein expression profile for the detection of mbcr/abl fusion and c-kit
- September 8th, 2008 - Nuclea Biotechnologies, llc will offer a new laboratory assay designed to detect the gene/protein expression profile indicative of irinotecan efficacy
- DFCI Impact Spring 2008 Nuclea Biotechnologies Drives Study into the Molecular Pathology of Cancer
- April 10th, 2008 - Nuclea Biotechnologies Announces That It Has Received a U.S. Patent on "Kinase Peptides and Andibodies"
Releases - 2007
-
2007
December 7th, 2007 - Nuclea Biotechnologies Establishes Research Collaboration with Clark University Involving Hermansky-Pudlak Syndrome -
WINTER/07
Nuclea Biotechnologies Targets Loda and Chin for Latest Gifts Dana Faber Cancer Institute Impact- Winter 2007 page 4 -
FALL/07
Nuclea Biotechnologies Fuels Cancer Pathology Studies Dana Faber Cancer Institute Impact- Fall 2007 page 4 - July 15th, 2007 - Nuclea Biotechnologies Renews Research Collaboration with Dana Farber Cancer Institute
- April 30th, 2007 - Nuclea Biotechnologies Establishes Research Collaboration with the Johns Hopkinds School of Medicine - JHSM will conduct research studies for development of TMAs using NCI-60 cell lines
- March 1st, 2007 - Nuclea Biotechnologies Establishes Research Collaboration with Dana Farber Cancer Institute Center for Molecular Oncologic Pathlogy
- February 20th, 2007 - Nuclea Biotechnologies Establishes Research Collaboration with Dana Farber Cancer Institute - Provides funds for lease of an Applied Biosystems Real Time PCR
Releases - 2006
-
2006
November 20th, 2006 - Nuclea Biotechnologies Announces the Development and Production of TMA Microarrays by Automated Methodology - November 16th, 2006 - Massachusetts Alliance for Economic Development (MAED) Announces Nuclea Biotechnologies is awarded economic impact award for emerging companies
- November 3rd, 2006 - Nuclea Biotechnologies Announces that it has Received a U.S. Design Patent on "Antibody Protein Analysis Chip"
- September 27th, 2006 - Massachusetts Alliance for Economic Development (MAED) Announces winners for its third annual team massachusetts economic impact awards
- June 5th, 2006 - Nuclea Biotechnologies Announces it has Received a Notice of Allowance for U.S. Design Patent
- May 1st, 2006 - Nuclea Biotechnologies Establishes Research Fellowship in the Laboratory of Dr. Massimo Loda of Dana Farber Cancer Institute
- Press In the News
03/08/06 - Berkshire Economic Development Corporation
Biotech firm on its way